Catherine C Schneider, M.D. Obstetrics & Gynecology Medicare: May Accept Medicare Assignments Practice Location: 500 Rushing Dr, Herrin, IL 62948 Phone: 618-998-8808 Fax: 618-998-8809 |
Amanda D. Mulch, M.D. Obstetrics & Gynecology - Obstetrics Medicare: May Accept Medicare Assignments Practice Location: 500 Rushing Dr, Herrin, IL 62948 Phone: 618-998-8808 |
Paul J Cruz, Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 3303 Logan Dr, Rea Clinic Herrin, Herrin, IL 62948 Phone: 618-993-5767 Fax: 618-724-2571 |
Mr. Francis H Tsung, M.D. Obstetrics & Gynecology Medicare: May Accept Medicare Assignments Practice Location: 500 Rushing Dr, Herrin, IL 62948 Phone: 618-998-8808 Fax: 618-998-8809 |
Joseph C Tsung, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 500 Rushing Dr, Herrin, IL 62948 Phone: 618-998-8808 Fax: 618-998-8809 |
News Archive
Sequential treatment with sorafenib followed by sunitinib is not superior to sunitinib followed by sorafenib in patients with advanced or metastatic renal cell carcinoma, suggests research published in European Urology.
BIO-key International, Inc., a leader in finger-based biometric identification solutions announced the award of another contract for a fingerprint biometric identity solution built on the fusion of BIO-key and MorphoTrak algorithms. The first contract for this fused solution, awarded to MorphoTrak (a Morpho company) by Lockheed Martin in September 2009, provides fingerprint identification technology for the FBI's Next Generation Identification (NGI) system. This new contract will provide large scale advanced finger matching technology to an overseas customer.
Massachusetts Gov. Deval Patrick says he and legislative leaders are in fundamental agreement over what should be included in a municipal health care bill, even while there remains disagreement on the specifics. The House approved a measure last week that would largely strip public employee unions of collective bargaining rights over health care benefits. The Senate is expected to act in the coming weeks.
Critical Outcome Technologies Inc. today announced positive results from the first phase of its HIV integrase inhibitor discovery program. These results provide novel intellectual property to the Company and further validation of the CHEMSAS® drug discovery technology.
Ortho-McNeil Neurologics Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., today announced it is voluntarily recalling two lots of TOPAMAX® (topiramate) 100mg Tablets. These two lots were shipped between 10/19/2010 and 12/28/2010 and distributed in the U.S. and Puerto Rico.
› Verified 9 days ago